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Abstract
Background: Hypohidrotic ectodermal dysplasia (HED) is a genetic disorder characterized by
defective development of teeth, hair, nails and eccrine sweat glands. Both autosomal dominant and
autosomal recessive forms of HED have previously been linked to mutations in the ectodysplasin
1 anhidrotic receptor (EDAR) protein that plays an important role during embryogenesis.
Methods: The coding DNA sequence of the EDAR gene was analyzed in two large Swedish three-
generational families with autosomal dominant HED.
Results: A non-sense C to T mutation in exon 12 was identified in both families. This disease-
specific mutation changes an arginine amino acid in position 358 of the EDAR protein into a stop
codon (p.Arg358X), thereby truncating the protein. In addition to the causative mutation two
polymorphisms, not associated with the HED disorder, were also found in the EDAR gene.
Conclusion: The finding of the p.Arg358X mutation in the Swedish families is the first
corroboration of a previously described observation in an American family. Thus, our study
strengthens the role of this particular mutation in the aetiology of autosomal dominant HED and
confirms the importance of EDAR for the development of HED.
Background
Hypohidrotic ectodermal dysplasia (HED) is a congenital
disorder characterized by abnormal morphogenesis of
structures of ectodermal origin that may result in varying
degrees of ectodermal defects such as hypodontia or ano-
dontia, hypotrichiosis or alopecia, hypohidrosis or anhid-
rosis as well as nail abnormalities [1]. Conical teeth are a
telltale sign in the HED patients, however other symp-
toms may vary between different individuals, even within
the same family. The reduced or absent ability to regulate
body temperature by sweating may lead to life-threaten-
ing hyperthermia, especially in very young children with
an undiagnosed disorder.
The most prevalent form of HED is inherited as an X-
linked condition [2] but autosomal dominant [3] and
autosomal recessive [4] forms of the disorder are also
found, albeit at a much lower frequency. According to the
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iants appears to be the respective inheritance pattern [5].
HED may result from defects in any of three interacting
proteins; ectodysplasin, EDAR or EDARADD. Ectodyspla-
sin [6] is a soluble ligand protein that interacts with the
transmembrane receptor EDAR, ectodysplasin 1 anhid-
rotic receptor [7-10] that is a death domain containing
member of the tumor-necrosis factor receptor family. The
intracellular part of EDAR subsequently binds to the
adapter protein EDARADD (EDAR-associated death
domain [11]) that links the receptor to downstream NF-
κB signaling pathways [12].
Mutations in the gene coding for ectodysplasin, EDA situ-
ated on chromosome Xq12-q13.1, were the first to be
found linked to HED [13]. The two most common splice
isoforms of EDA (EDA-A1 and EDA-A2) bind the two dis-
tinct receptors EDAR and XEDAR respectively. They dis-
play different functions, where EDA-A1 appears to be
essential for several skin appendages, and EDA-A2 proba-
bly is responsible for developmental timing and comple-
tion [14]. Later, both autosomal dominant and
autosomal recessive variants of HED were found to be
caused by different mutations in the EDAR gene on chro-
mosome 2q11-q13 [15]. Autosomal recessive HED was
also found to result from a mutation in the EDARADD
gene on chromosome 1q42.2-q43 [16]. Interestingly,
HED caused by mutations in either EDA or EDAR has
been detected in several other species, including cattle
[17], dogs [18] and mice [9,19,20]. Here we report the
identification of a non-sense mutation in the EDAR gene




Two families from the same geographical region in north-
ern Sweden were investigated in this study. Both families
included several members who suffered from various
symptoms of AD HED (Fig. 1). Approval from the local
medical ethics committee was obtained prior to the onset
of the study and genetic material was obtained from the
subjects after informed consent was obtained. Genomic
DNA was prepared from buccal swabs from 18 individu-
als (15 AD HED patients and three unaffected relatives)
according to standard protocols.
Clinical description
The phenotype of the AD HED patients included hypo-
dontia with varying number of primary and permanent
teeth absent (Fig. 2), hypohidrosis, and mild hypotrichio-
sis in accordance with an earlier description of AD HED
[21,22]. The affected individuals from the Swedish fami-
lies lacked 3 to 16 permanent teeth and a common sign
observed in all affected persons was the absence of 1 to 4
permanent mandibular incisors. In addition to the dental
anomalies the affected family members showed varying,
but general mild, symptoms from skin and hair.
PCR amplification of genomic DNA, DHPLC analysis and 
mutation detection
The EDAR gene was screened for mutations by denaturing
high performance liquid chromatography (DHPLC) [23]
of PCR products from eleven EDAR exons with flanking
intron sequences (Table 1). Ten intronic oligonucleotide
primer pairs for the EDAR gene were designed from the
genomic sequence NT_022171 [24]. PCR products were
amplified from a nuclear AD HED family of four individ-
uals (Family A individuals IV:1, IV:2, V:1 and V:2) as well
as one more distantly related AD HED patient and two
unrelated healthy individuals. Initially temperature gradi-
ent PCR was used to determine the optimal annealing
temperature for each primer pair, after which all individ-
ual samples were amplified by PCR and subjected to het-
eroduplex formation, in which the PCR products were
slowly cooled from 95°C to room temperature, at 1.5°C/
min. During all thermal reactions a PTC-200 Peltier Ther-
mal Gradient Cycler (MJ Research, Waltham, MA, U.S.A.)
was used.
The Wavemaker™ software (Transgenomic, San Jose, CA,
USA) was used to predict the optimal temperature for het-
eroduplex separation and acetonitrile gradients. Heter-
oduplexes were resolved from the corresponding
homoduplexes using the WAVE system (Transgenomic,
San Jose, CA, USA), an automated HPLC with a DNA sep-
aration column.
Exon fragments that showed a suspected sequence varia-
tion co-segregating with the disease were bi-directionally
sequenced using Big Dye termination kit V3.0 (Amersham
Biosciences) and the ABI 3730 DNA analyzer (Applied
Biosystem). The same oligonucleotide primers that were
used for PCR amplification were also used in sequencing
reactions. Alignments and sequence comparisons were
carried out using the BioEdit 5.0.7 software [25].
Results
DHPLC analysis of amplified PCR products from the 11
coding EDAR exons obtained from affected and unaf-
fected family members indicated potential peak pattern
variations in some exons but it was only one prominent
variation that co-segregated with the disease phenotype.
This was a conspicuous alteration in the peak pattern for
exon 12, most noticeable at a denaturation temperature of
63°C. PCR fragments from exon 12 were subsequently bi-
directionally sequenced from affected and non-affected
individuals. Sequencing revealed a C to T transition at
nucleotide position c.1072 of the EDAR gene (Fig. 3).Page 2 of 8
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obtained from the EDAR mRNA sequence with the ATG
adenine as position +1 [26]. The mutation changes a CGA
arginine codon to a TGA stop codon and is present in all
affected, but no unaffected individual. In addition to the
terminating mutation, sequencing also revealed two poly-
morphisms not related to the disease symptoms, a silent
change at position c.1056 of a T to C in the third position
of a TGC cysteine codon, and a T to G exchange at posi-
tion c.1389 in the 3' untranslated region 42 nucleotides
downstream of the native stop codon in exon 12.
Discussion
In this report we have studied two presumed unrelated
Swedish AD HED families stemming from the same small
geographical region, and have identified an identical C to
T mutation in exon 12 of the EDAR gene present in
patients from both families. The mutation changes an
arginine CGA codon into a TGA nonsense codon, thus
introducing a truncation of the cytoplasmic portion of the
EDAR protein at amino acid position 358. Thereby the
p.Arg358X mutation leads to complete abolishment of
the death domain region, amino acid 367 to amino acid
431, of the EDAR protein.
Two additional genetic variants were also detected in the
PCR fragment that contained exon 12 of the EDAR gene;
one polymorphism was a silent change, a T to C, just 15
nucleotides upstream of the p.Arg358X mutation, the
other polymorphism, a T to G change, was located in the
untranslated region downstream of the native stop codon
of the EDAR gene. None of these polymorphisms appear
to be associated with the AD HED disease, since the first
variant was found both in a few healthy and in affected
Pedigrees of two Swedish families with autosomal dominant hypohidrotic ectodermal dysplasiaFigu  1
Pedigrees of two Swedish families with autosomal dominant hypohidrotic ectodermal dysplasia. Round symbols 
denotes women; square symbols, men; filled symbols, individuals affected by AD HED; * individuals subjected to DNA sequenc-
ing. The nuclear family chosen for the initial screening of EDAR and the girl shown in figure 2 are indicated by boxes.
Family A
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Dental abnormalities in a 5-year-old girl from family AFigure 2
Dental abnormalities in a 5-year-old girl from family A. a) Intraoral view. Note that the upper incisors have been 
restored with composite material to disguise their original conical shape. b) Ortopantomogram showing absence of ten pri-
mary and 11 permanent teeth in the jaws of the same individual.
BMC Medical Genetics 2006, 7:80 http://www.biomedcentral.com/1471-2350/7/80individuals and the second variant was only detected in
two related healthy individuals, a parent and child. The
most frequent sequence variant in both polymorphic loci,
T, was found in homozygotic form at position c.1056 and
position c.1389 in both healthy and affected individuals.
Interestingly, the first polymorphism, c.1056 T to C was
also detected in a previous study [15], but in that material
the C allele was predominant and not the T allele as in our
study. Likewise, in the published EDAR sequence [26] the
nucleotide at position c.1389 is given as G, whereas in our
material the G allele was only present as one copy each in
two related individuals and all other individuals were
homozygous for the T allele.
No known relationship exists between the two Swedish
AD HED families, but since both families carry the same
p.Arg358X mutation it is tempting to speculate that there
is a previously unidentified relationship, especially when
considering that the families originate from the same
restricted geographical area.
All individuals affected by AD HED demonstrated absence
of permanent teeth, albeit the actual number of missing
teeth differed between the patients. Apart from the obli-
gate odontological findings, other ectodermal symptoms
were non-specific and, if present, generally mild. This is in
contrast to a recently described family with AD HED
where the affected individuals appear to have more pro-
nounced symptoms overall [27]. Even though the actual
mutation has not been identified in that family the dis-
ease gene maps to the same chromosomal region as the
EDAR gene and it is very plausible that a mutation in the
EDAR gene is the culprit in that AD HED family also.
The variable degree of expression of symptoms in individ-
uals with AD HED is interesting and can probably be
explained to some extent by different causative mutations.
However, the variability of symptoms in teeth and other
organs in individuals carrying the same EDAR mutation is
intriguing and invites speculation to the cause. At least
three different scenarios can be envisioned, two directly
related to the nature of the EDAR mutation and one
involving other gene products. The dominant negative
action of the p.Arg358X mutation in AD HED could result
from prevention of proper trimerization of the TNFR-like
EDAR protein due to the lack of an intact death domain.
Functional EDAR trimer complexes are required for accu-
rate interactions with EDARADD and subsequent intracel-
lular signaling [16]. Since EDAR trimers in AD HED
patients most likely are formed by random combinations
of normal and mutant variants of the protein, the propor-
tion of functional EDAR homo-trimers in different indi-
viduals during embryogenesis and later developmental
stages could vary. This variation could lead to a more or
less severe clinical outcome due to chance deviations in
the level of proper cell signaling in the ectoderm. An alter-
native explanation for the dominant-negative effect of the
p.Arg358X mutation might be that the mutation leads to
an altered subcellular location of the protein as compared
to the non-mutated protein in analogy to what has been
observed in studies of the orthologous mutated and wild-
type Edar protein in mouse cell cultures [28]. A third sce-
nario might be dissimilarities in the interactions between
the mutant EDAR protein and different non-pathogenic
variants of the ectodysplasin and EDARADD proteins.
So far, a limited number of EDAR mutations have been
reported; five dominant mutations [15,29], six
homozygous recessive mutations [15,29,30], and five
compound heterozygous recessive cases [15,29,31],
(Table 2). Interestingly, the mutation detected in the
Swedish families is the same as one of the first autosomal
dominant mutations described [15]. One of the two pre-
viously studied American families with autosomal domi-
nant HED [15] was first described in 1987 [22] but it is
unclear which mutation is carried in this family. The rea-
son for identical mutations found in families on two dif-
ferent continents is not known. Perhaps there is a
Table 1: Primers used in the analysis of the EDAR gene. Intronic primer sequences, annealing temperatures and sizes of PCR products 
suitable for DHPLC analysis and DNA sequencing of the EDAR gene.
Exon no. Forward primer (5'-3') Reverse primer (5'-3') Optimal annealing temp.* (°C) Fragment size (bp)
2 TTTGCTGGAAGGCACCTTAT AGAGGCCAAGAAACAGTCCA 58–62 243
3 ACCCCCTTCCTATGTCAACC CAGGCTCAGGGCAACAAT 56–62 292
4 CGGCAAGAGTAGCTTCTGGA GCAGTATCCATGACCCCTGT 51–63 397
5 GTGCTCTCTGCACCAGTCC GACCGGCTCTTTCCTACACC 52–63 246
6 AGCTCTGTGGCAGCGTCT CCTCTCCTCTTCTGAGCTTTCA 51–62 228
7 + 8 GGAGTCCTGGAGGGAAGACC AGCATGTGAGAGCAGAAGCA 60 468
9 AGAGCAGGGTTGGGCTGAG GCTAGCCTGTCAGTTCACTCG 51–63 248
10 AGGTGCCCAGTAAACACCTG CGTCTTGCAGGAGAGCTGAT 51–63 400
11 CCTGCTGACATGGAGGATTT CTCAGTTCCCCTCACAGGAG 51–63 234
12 GACCTTCTATTGACTGTGACTTGC CAGTCTTTTGGCACCACTCA 51–63 461
*As indicated by gradient PCR reactions.Page 5 of 8
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DHPLC and sequence variance in affected and non-affected individualsFigure 3
DHPLC and sequence variance in affected and non-affected individuals. DNA sequence from exon 12 of the EDAR 
gene in an AD HED patient. An arrow indicates the disease associated C/T mutation in sequence position c.1072.
CGA = Arginine
G  A  C  T  A  G  C  C/T  G  A  A  T  G  C  T
TGA = Stop
BMC Medical Genetics 2006, 7:80 http://www.biomedcentral.com/1471-2350/7/80preference for mutations of the C in position c.1072 or it
might even be that the Swedish and American families are
related since many residents of Sweden migrated to North
America during previous centuries.
Conclusion
This is the first study corroborating the p.Arg358X muta-
tion in the EDAR gene and it supports the notion that
EDAR is one of the key proteins in the development of
HED. Thus, our report strengthens the role of this particu-
lar mutation in the etiology of autosomal dominant HED
and confirms the importance of EDAR in the develop-
ment of HED.
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Table 2: HED mutations in the EDAR gene
Inheritance Genotype Location Sequence change* Protein change Predicted effect Reference
AD heterozygous exon 12 c.1072C→T Arg358Ter truncated protein, 
no DD
present study, [15]
c.1129C→T Leu377Phe altered DD [29]
c.1237A→C Thr413Pro [29]
c.1253T→C Ile418Thr ° [29]
1259G→A Arg420Gln [15] [29]
AR homozygous intron 2 ∆IVS2 -25 to -8 disturbed splicing of exon 3 [15]
exon 4 c.259T→C Cys87Arg altered LBD [15]
exon 8 c.718∆AAAG frame shift truncated protein, 
no trimers formed
[30]
exon 12 c.1144G→A Gly382Ser altered DD [30]
exon 12 c.1208C→T Thr403Met altered DD [29]
exon 12 c.1302G→T Trp434Cys altered DD [29]
compound 
heterozygous
intron 2 IVS2 +1G→A exon 3 skipping no stable transcript [31]
exon 12 c.1124G→A Arg375His altered DD
exon 3 c.140G→A Cys47Tyr altered LBD [29]
intron 6 IVS6+1G→A disturbed splicing of exon 6
exon 4 c.266G→A Arg89His altered LBD [15]
at least exon 4 ∆ ≥ exon 4 ? no protein?
exon 4 c.266G→T Arg89His altered LBD [29]
intron 6 IVS6+1G→A disturbed splicing of exon 6
exon 4 c.329A→C Asp110Ala altered LBD [29]
exon 5 c.442T→C Cys148Arg altered LBD
HED, hypohidrotic ectodermal dysplasia; EDAR, ectodysplasin 1 anhidrotic receptor; AD, autosomal dominant; AR, autosomal recessive; ° 
presumed AD; DD, death domain; LBD, ligand binding domain; ∆, deletion; IVS, intervening sequence.
* Sequence positions according to the EDAR cDNA sequence with the initiator adenine as position +1 [26].Page 7 of 8
(page number not for citation purposes)
BMC Medical Genetics 2006, 7:80 http://www.biomedcentral.com/1471-2350/7/80Publish with BioMed Central   and  every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright




1. Pinheiro M, Freire-Maia N: Ectodermal dysplasias: a clinical clas-
sification and a causal review.  Am J Med Genet 1994,
53(2):153-162.
2. OMIM - ECTODERMAL DYSPLASIA 1, ANHIDROTIC;
ED1   [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=305100]
3. OMIM - ECTODERMAL DYSPLASIA 3, ANHIDROTIC;
ED3   [http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=129490]
4. OMIM - ECTODERMAL DYSPLASIA, ANHIDROTIC   [http:/
/www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=224900]
5. Munoz F, Lestringant G, Sybert V, Frydman M, Alswaini A, Frossard
PM, Jorgenson R, Zonana J: Definitive evidence for an autosomal
recessive form of hypohidrotic ectodermal dysplasia clini-
cally indistinguishable from the more common X-linked dis-
order.  Am J Hum Genet 1997, 61(1):94-100.
6. OMIM - ED1 GENE; ED1   [http://www.ncbi.nlm.nih.gov/entrez/
dispomim.cgi?id=300451]
7. OMIM - ECTODYSPLASIN 1, ANHIDROTIC RECEPTOR;
EDAR   [http://www.ncbi.nlm.nih.gov/entrez/dispo
mim.cgi?id=604095]
8. Elomaa O, Pulkkinen K, Hannelius U, Mikkola M, Saarialho-Kere U,
Kere J: Ectodysplasin is released by proteolytic shedding and
binds to the EDAR protein.  Hum Mol Genet 2001, 10(9):953-962.
9. Headon DJ, Overbeek PA: Involvement of a novel Tnf receptor
homologue in hair follicle induction.  Nat Genet 1999,
22(4):370-374.
10. Yan M, Wang LC, Hymowitz SG, Schilbach S, Lee J, Goddard A, de
Vos AM, Gao WQ, Dixit VM: Two-amino acid molecular switch
in an epithelial morphogen that regulates binding to two dis-
tinct receptors.  Science 2000, 290(5491):523-527.
11. OMIM - EDAR-ASSOCIATED DEATH DOMAIN; EDAR-
ADD   [http://www.ncbi.nlm.nih.gov/entrez/dispo
mim.cgi?id=606603]
12. Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A,
Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia
SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K,
Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kal-
hoff H, Abinun M, Munnich A, Israel A, Courtois G, Casanova JL: X-
linked anhidrotic ectodermal dysplasia with immunodefi-
ciency is caused by impaired NF-kappaB signaling.  Nat Genet
2001, 27(3):277-285.
13. Kere J, Srivastava AK, Montonen O, Zonana J, Thomas N, Ferguson
B, Munoz F, Morgan D, Clarke A, Baybayan P, Chen EY, Ezer S, Saar-
ialho-Kere U, de la Chapelle A, Schlessinger D: X-linked anhidrotic
(hypohidrotic) ectodermal dysplasia is caused by mutation in
a novel transmembrane protein.  Nat Genet 1996,
13(4):409-416.
14. Srivastava AK, Durmowicz MC, Hartung AJ, Hudson J, Ouzts LV,
Donovan DM, Cui CY, Schlessinger D: Ectodysplasin-A1 is suffi-
cient to rescue both hair growth and sweat glands in Tabby
mice.  Hum Mol Genet 2001, 10(26):2973-2981.
15. Monreal AW, Ferguson BM, Headon DJ, Street SL, Overbeek PA,
Zonana J: Mutations in the human homologue of mouse dl
cause autosomal recessive and dominant hypohidrotic ecto-
dermal dysplasia.  Nat Genet 1999, 22(4):366-369.
16. Headon DJ, Emmal SA, Ferguson BM, Tucker AS, Justice MJ, Sharpe
PT, Zonana J, Overbeek PA: Gene defect in ectodermal dyspla-
sia implicates a death domain adapter in development.
Nature 2001, 414(6866):913-916.
17. Drogemuller C, Peters M, Pohlenz J, Distl O, Leeb T: A single point
mutation within the ED1 gene disrupts correct splicing at
two different splice sites and leads to anhidrotic ectodermal
dysplasia in cattle.  J Mol Med 2002, 80(5):319-323.
18. Casal ML, Scheidt JL, Rhodes JL, Henthorn PS, Werner P: Mutation
identification in a canine model of X-linked ectodermal dys-
plasia.  Mamm Genome 2005, 16(7):524-531.
19. Ferguson BM, Brockdorff N, Formstone E, Ngyuen T, Kronmiller JE,
Zonana J: Cloning of Tabby, the murine homolog of the
human EDA gene: evidence for a membrane-associated pro-
tein with a short collagenous domain.  Hum Mol Genet 1997,
6(9):1589-1594.
20. Srivastava AK, Pispa J, Hartung AJ, Du Y, Ezer S, Jenks T, Shimada T,
Pekkanen M, Mikkola ML, Ko MS, Thesleff I, Kere J, Schlessinger D:
The Tabby phenotype is caused by mutation in a mouse
homologue of the EDA gene that reveals novel mouse and
human exons and encodes a protein (ectodysplasin-A) with
collagenous domains.  Proc Natl Acad Sci U S A 1997,
94(24):13069-13074.
21. Aswegan AL, Josephson KD, Mowbray R, Pauli RM, Spritz RA, Wil-
liams MS: Autosomal dominant hypohidrotic ectodermal dys-
plasia in a large family.  Am J Med Genet 1997, 72(4):462-467.
22. Jorgenson RJ, Dowben JS, Dowben SL: Autosomal dominant
ectodermal dysplasia.  J Craniofac Genet Dev Biol 1987,
7(4):403-412.
23. Xiao W, Oefner PJ: Denaturing high-performance liquid chro-
matography: A review.  Hum Mutat 2001, 17(6):439-474.
24. NCBI Sequence Viewer v2.0  NT_022171
[http:www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucle
otide&val=88953465]
25. Hall TA: BioEdit: a user friendly biological sequence align-
ment editor and analysis program for Windows 95/98/NT.
Nucleic Acids Symposium Series 1999, 41:95-98.
26. NCBI Sequence Viewer v2.0  NM_02336
[http:www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db=nucle
otide&val=11641230]
27. Rodrigues RG: Three successive generations of women with
anhidrotic/hypohidrotic ectodermal dysplasia.  J Natl Med
Assoc 2005, 97(1):99-101.
28. Koppinen P, Pispa J, Laurikkala J, Thesleff I, Mikkola ML: Signaling
and subcellular localization of the TNF receptor Edar.  Exp
Cell Res 2001, 269(2):180-192.
29. Chassaing N, Bourthoumieu S, Cossee M, Calvas P, Vincent MC:
Mutations in EDAR account for one-quarter of non-ED1-
related hypohidrotic ectodermal dysplasia.  Hum Mutat 2006,
27(3):255-259.
30. Naeem M, Muhammad D, Ahmad W: Novel mutations in the
EDAR gene in two Pakistani consanguineous families with
autosomal recessive hypohidrotic ectodermal dysplasia.  Br J
Dermatol 2005, 153(1):46-50.
31. Shimomura Y, Sato N, Miyashita A, Hashimoto T, Ito M, Kuwano R:
A rare case of hypohidrotic ectodermal dysplasia caused by
compound heterozygous mutations in the EDAR gene.  J
Invest Dermatol 2004, 123(4):649-655.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/7/80/prepubPage 8 of 8
(page number not for citation purposes)
